SL
IART icon

Salomon & Ludwin’s Integra LifeSciences IART Stock Holding History

Salomon & Ludwin’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.2K Sell
1,965
-768
-28% -$10.7K ﹤0.01% 741
2026
Q1 		$26K Buy
2,733
+2,480
+980% +$27.2K ﹤0.01% 896
2025
Q4 		$3.18K Sell
253
-351
-58% -$4.67K ﹤0.01% 1921
2025
Q3 		$8.94K Buy
+604
New +$8.27K ﹤0.01% 1396

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Salomon & Ludwin's IART Position: Q2 2026 in Review

Salomon & Ludwin reduced its Integra LifeSciences (IART) stake by 28% in Q2 2026, selling an estimated $10.7K and leaving 1,965 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #741.

Salomon & Ludwin first reported a position in IART in Q3 2025 and has held it in 4 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Salomon & Ludwin held 1,965 shares of Integra LifeSciences worth $35.2K as of Q2 2026.
  • Salomon & Ludwin sold 768 Integra LifeSciences shares in Q2 2026, an estimated $10.7K.
  • Integra LifeSciences made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #741 holding.
  • Salomon & Ludwin first reported a position in Integra LifeSciences in Q3 2025 and has held it in 4 quarters since.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.